Repeated periocular and facial irradiation contributes to lasting cosmetic and functional changes that can intensify distress ...
Yerkes described this period not as a recovery, but as a navigation of a "new normal." For many survivors, the mirror becomes ...
The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III ...
The National Ovarian Cancer Coalition (NOCC) delivers free meals to ovarian cancer patients, easing treatment burdens and ...
Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms ...
Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.
At the 2026 NCCN Annual Meeting, CURE sat down with Dr. Thomas Flaig to discuss the rapidly evolving landscape of bladder ...
Your study found that analyzing specific bacterial groups in the in the gut could predict melanoma recurrence with a very ...
Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with ...
Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite ...
Cancer care is not experienced equally across the globe. Speaking at the 2026 NCCN Annual Conference, Caroline Taylor, ...
Gratitude is framed as the central mechanism enabling emotional regulation, meaning-making, and perseverance through colon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results